Company intelligence / Profile preview

CeGaT

Tübingen, Baden-Württemberg, Germanycegat.com ↗

Ownership: Private
Development stage: Commercial

Overview

CeGaT is a leading European provider of next-generation sequencing-based genetic diagnostics for rare diseases, hereditary cancers, and other medical indications. The company also offers research sequencing services for clinical trials and pharmaceutical R&D. It holds multiple international accreditations including CAP/CLIA/ISO15189

Therapeutic areas: OncologyRare DiseasesCardiovascularOphthalmologyNeurologyWomen's Health
Industry: Molecular Diagnostics

Partnerships

B. Braun China (clinical genetic testing in China)Collaborations with Evotec, Vaccibody, Cellestia, LGC Biosearch Technologies, EORTC among others for research & pharma solutions

Beyond the preview

Go deeper on CeGaT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CeGaT.